Salem Investment Counselors’s Journey Medical DERM Stock Holding History
Bought
Maintained
Sold
Other funds holding DERM
WA
PAM
GIA
AI
EWA
FFA
Salem Investment Counselors's DERM Position: Q2 2026 in Review
Salem Investment Counselors increased its Journey Medical (DERM) stake by 104% in Q2 2026, buying an estimated $85.1K and bringing the position to 29,200 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #407.
Salem Investment Counselors first reported a position in DERM in Q3 2025 and has held it in 4 quarters since. 7 funds tracked by Wall St. Rank hold DERM as of Q2 2026.
- Salem Investment Counselors held 29,200 shares of Journey Medical worth $207K as of Q2 2026.
- Salem Investment Counselors bought 14,900 Journey Medical shares in Q2 2026, an estimated $85.1K.
- Journey Medical made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #407 holding.
- Salem Investment Counselors first reported a position in Journey Medical in Q3 2025 and has held it in 4 quarters since.
- 7 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.